文献速递妇科

卵巢癌患者按自我报告祖先来源的致病性胚系变异:一项商业实验室协作研究登记研究

Pathogenic germline variants among patients with ovarian cancer by self-reported ancestry: A commercial laboratory collaborative research registry study.
PubMed 文献 · Gynecol Oncol · 2025-11-12

该研究基于Myriad协作研究登记,分析84,396例上皮性卵巢癌患者的胚系检测数据,总体致病性胚系变异率为16.1%,Ashkenazi犹太裔最高(24.4%),西班牙裔(18.8%)、亚裔(17.4%)和白人(15.6%)也较高,支持普遍胚系检测建议。

要点

  • 84,396例卵巢癌患者中16.1%携带致病性胚系变异,支持普遍胚系检测。
  • Ashkenazi犹太裔致病性胚系变异率最高(24.4%),西班牙裔和亚裔也较高。
  • 同源重组相关基因变异占多数(13.8%),Lynch综合征相关变异占0.92%。

核心结论

  • 在超过84,000例卵巢癌患者中,16.1%携带致病性胚系变异,支持普遍胚系检测的建议。

研究设计与样本

  • 从公开的Myriad协作研究登记中识别接受胚系检测的上皮性卵巢癌患者,按自我报告祖先来源计算致病性胚系变异率。

主要发现

  • 84,396例卵巢癌患者中,55,984例(66.3%)为白人,6,099例(7.2%)为西班牙裔,4,440例(5.3%)为黑人,3,628例(4.3%)为Ashkenazi犹太裔,2,900例(3.4%)为亚裔,19,706例(23.3%)为其他。
  • 总体13,554例(16.1%)携带致病性胚系变异,Ashkenazi犹太裔最高(24.4%),其次为西班牙裔(18.8%)、亚裔(17.4%)和白人(15.6%),p < 0.0001。
  • 同源重组相关基因(主要为BRCA1/2)致病性胚系变异见于11,661例(13.8%),不同祖先来源间差异显著,p < 0.001;Ashkenazi犹太裔最高(23.7%),西班牙裔(16.8%)、亚裔(15.6%)、黑人(14.9%)和白人(13.1%)相近。
  • Lynch综合征相关致病性胚系变异见于778例(0.92%),亚裔最高(1.3%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Ovarian cancer (OC) is highly lethal, and ∼15-20 % of cases occur in patients with germline pathogenic variants (gPVs) in BRCA1/2 and other genes related to homologous recombination (HR) and mismatch repair. We sought to characterize the germline landscape of patients with OC by self-identified ancestry. METHODS: Patients with epithelial OC who received germline testing were identified from the publicly available Myriad Collaborative Research Registry. Rates of gPVs were calculated, overall and by self-reported ancestry, with a focus on HR-related and Lynch syndrome (LS)-associated genes. RESULTS: Among 84,396 patients with OC, 55,984 (66.3 %) identified as White, 6099 (7.2 %) as Hispanic, 4440 as Black (5.3 %), 3628 (4.3 %) as Ashkenazi Jewish (AJ), 2900 (3.4 %) as Asian, and 19,706 (23.3 %) as Other. Overall, 13,554 (16.1 %) patients had a gPV, with highest rates among AJ (24.4 %), followed by Hispanic (18.8 %), Asian (17.4 %), and White (15.6 %) patients, p < 0.0001. Most gPVs were in HR genes, specifically BRCA1/2, and occurred in 11,661 (13.8 %) patients with significant differences by ancestry, p < 0.001. The highest gPV rates in HR- related genes were in those of AJ ancestry (23.7 %) with similar rates in Hispanic (16.8 %), Asian (15.6 %), Black (14.9 %), and White (13.1 %) populations. Lynch syndrome gPVs were found in 778 (0.92 %) patients with highest rates in Asians (1.3 %). CONCLUSIONS: Among >84,000 patients with OC, 16.1 % had a gPV, supporting recommendations for universal germline testing. Although those of AJ ancestry had the highest prevalence of gPV, Hispanic and Asian patients also had high gPV rates, supporting inclusive testing strategies given universal recommendations.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Aryasomayajula C, Johnson CR, Francoeur AA, et al. Pathogenic germline variants among patients with ovarian cancer by self-reported ancestry: A commercial laboratory collaborative research registry study. Gynecol Oncol. 2025. PMID: 41232208. doi:10.1016/j.ygyno.2025.11.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。